FIELD: medicine.
SUBSTANCE: what is offered is application of 3-bromophascaplysin as an agent preventing mammal normal cell transformation in malignant cells, and also for preparation of pharmaceutical compositions of given (cancer-preventive) action. It is shown that 3-bromophascaplysin exhibits a cancer-preventive effect in the concentration non-cytotoxic for normal cells.
EFFECT: higher clinical effectiveness.
2 cl, 2 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT PREVENTING MAMMAL NORMAL CELL TRANSFORMATION IN MALIGNANT CELLS | 2010 |
|
RU2429840C1 |
| MEDICATION INFLUENCING ACTIVITY OF SOME NUCLEAR TRANSCRIPTION FACTORS | 2011 |
|
RU2457840C1 |
| GLYCOSIDE DERIVATIVES OF 1,2-DITHIOL-3-THIONE OR 1,2-DITHIOL-3-ONE AND PHARMACEUTICAL PRODUCTS BASED ON THEM | 2013 |
|
RU2534525C9 |
| THERAPEUTIC QUINONES | 2005 |
|
RU2411229C2 |
| TORK PROTEIN KINASE INHIBITOR WITH DIRECTED CHEMOPREVENTIVE EFFECT IN VITRO | 2014 |
|
RU2566268C1 |
| ANTICANCER DRUG | 2009 |
|
RU2414920C1 |
| MONONECLEAR DINITROSYL FERRIC COMPLEXES, METHOD FOR PREPARING MONONECLEAR DINITROSYL FERRIC COMPLEXES, NITROGEN MONOXIDE DONOR, USING MONONECLEAR DINITROSYL FERRIC COMPLEXES AS ANTI-TUMOUR DRUG | 2011 |
|
RU2494104C2 |
| HUMAN BREAST CANCER CELL LINE BrCCh4e | 2019 |
|
RU2717654C1 |
| CYTOTOXIC AND ANTIVIRAL ACTIVITY OF 3-ACYLOXYMETHYL-3-OXO-1-CYANO-2,3-SECO-2-NOR-TRITERPENOIDS | 2018 |
|
RU2686100C1 |
| PEPTIDE EXHIBITING ANTIBACTERIAL AND ANTITUMOUR PROPERTIES | 2019 |
|
RU2702661C1 |
